本文へ移動
cccskills
無料GitHub で公開

esa-pa-pediatric-bp-target

Establishes age- and gender-specific blood pressure goals for pediatric patients with primary aldosteronism (PA) using published normative data to assess treatment adequacy and avoid over-treatment. Use when managing hypertension in children with PA to evaluate if BP is adequately controlled; triggers include pediatric PA hypertension, BP not normalized with glucocorticoid therapy, and need for age‑specific BP targets.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.5 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Determine Blood Pressure Targets for Children with PA

STEP 1 — Gather Information

Collect patient age (years), sex, height (or BMI), weight, current systolic/diastolic BP, glucocorticoid type and dose, confirmation of PA (e.g., GRA genotype or clinical diagnosis), and any comorbidities. → Proceed to STEP 2.

STEP 2 — Rule In / Rule Out

Determine if the patient is a child (<18 years) with confirmed PA requiring glucocorticoid therapy; if not, the skill does not apply (stop). If yes, proceed to STEP 3.

STEP 3 — Classify or Stratify

Using age‑, sex‑, and height‑specific normative BP tables (e.g., NIH childhood BP percentiles), calculate the 90th percentile systolic and diastolic BP as the treatment target; if height unavailable, use age‑sex 90th percentile from population norms. → Proceed to STEP 4.

STEP 4 — Decide

If current BP ≤ target, maintain current glucocorticoid dose; if current BP > target, consider increasing glucocorticoid dose (weight‑adjusted) or adding an MR antagonist, then re‑evaluate BP in 2–4 weeks. → End.

Clinical Guardrails / Mimics / Pitfalls

Avoid excessive glucocorticoid dosing that can cause growth retardation, cushingoid features, or adrenal suppression; do not apply adult BP thresholds (140/90 mmHg) to children; ensure normative data match the child's ethnicity and height; monitor for hypokalemia when adding MR antagonist; do not ignore weight‑based glucocorticoid adjustments.

Concrete Clinical Example

9‑year‑old girl with GRA on prednisone 5 mg daily, BP 128/82 mm Hg, height 130 cm (50th percentile). Age‑sex‑height 90th percentile BP is 115/72 mm Hg; current BP exceeds target, so increase prednisone to 7.5 mg daily and recheck BP in 3 weeks.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-4061

TODO: consider adding scripts/calc.py for the esa-pa-pediatric-bp-target calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する